
The insurer posted adjusted earnings of $0.58 per share and raised its full-year adjusted EPS floor to more than $5.20.
Centene raised its 2026 earnings outlook after reporting third-quarter adjusted earnings of $0.58 per share. The company posted a GAAP diluted loss of $0.14 per share.
The insurer now expects full-year adjusted diluted EPS above $5.20, an increase of $0.40 to its guidance floor. Its GAAP diluted EPS guidance floor is now above $3.46.
Third-quarter premium and service revenues rose 0.5% from a year earlier to $45.1 billion. Centene’s health benefits ratio, which measures medical costs against premium revenue, was 92.7%, unchanged from the year-earlier quarter.
The company said the consolidated ratio benefited from improved Marketplace pricing and strong performance in Medicare Advantage and its prescription drug plan business. Centene also lowered its full-year health benefits ratio guidance range to 90.4% to 91.1%.
Centene said it reduced debt by $1.1 billion since June 30, including by repurchasing the remaining $569 million of its 2027 senior notes in October. As of 19:59 UTC Tuesday, shares traded at $68.80, up 1.13% since the previous close.
This article was produced with the help of AI technology. Based on reporting by the outlets listed above.